Annovis Bio
ANVS
ANVS
30 hedge funds and large institutions have $10.6M invested in Annovis Bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+2
Holders Change %
+7.14%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
9
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.85M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$61.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$41.7K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$10K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.17K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WWP
26
WR Wealth Planners
Columbia,
Missouri
| $1.42K | – | – | – |
|
|
CAS
27
Coppell Advisory Solutions
Coppell,
Texas
| $998 | -$15.8K | -174 | -94% |
|
28
UBS Group
Zurich,
Switzerland
| $949 | – | – | – |
|
29
Qube Research & Technologies (QRT)
London,
United Kingdom
| $19 | +$19 | +2 | New |
|
|
LCM
30
Lynwood Capital Management
Toronto,
Ontario, Canada
| – | -$145K | -10,131 | Closed |
|